Riskpilot← Back to searchSign inGet full accessSOS EYE AS
ASActiveOrg 916562713Laueveien 1, 1481 HaganMedical specialists activities · NACE 8622Est. 20165 employees
Revenue 2021
NOK 8,1M
+8% vs 2020
EBITDA margin
26.2%
+9% vs 2020
Equity ratio
65.6%
Financial strength
Net profit 2021
NOK 1,8M
+114% vs 2020
| Revenue | NOK 8,1M | +8% |
| EBITDA | NOK 2,1M | +9% |
| Net profit | NOK 1,8M | +114% |
| Total assets | NOK 8,6M | +30% |
| Equity | NOK 5,6M | -4% |
| Employees | 5 | — |
Legal name
SOS EYE AS
Org number
916562713
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
14. januar 2016
Share capital
NOK 3 000 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Drift av øyelegepraksis og andre relaterte helsetjenester, investering og deltakelse i andre selskaper og eiendom, samt alt annet som naturlig faller inn under dette.
Address
Laueveien 1, 1481 Hagan
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 7 779 | 8 068 | 8 116 | 7 523 | 8 133 |
| Staff expenses | −2 237 | −2 102 | −2 197 | −2 011 | −2 221 |
| EBITDA | 1 849 | 1 894 | 2 351 | 1 952 | 2 128 |
| Depreciation & amort. | −247 | −255 | −351 | −395 | −204 |
| EBIT | 1 602 | 1 638 | 2 000 | 1 558 | 1 924 |
| Net financials | −1 | 6 | 44 | −444 | 275 |
| Profit before tax | 1 601 | 1 644 | 2 044 | 1 114 | 2 199 |
| Tax | 385 | 381 | 451 | 284 | 426 |
| Net profit | 1 216 | 1 264 | 1 593 | 830 | 1 774 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 4 325 | 5 312 | 6 894 | 6 576 | 8 580 |
| Equity | 3 538 | 4 552 | 6 025 | 5 855 | 5 629 |
| Long-term debt | 13 | 0 | 0 | 0 | 0 |
| Short-term debt | 774 | 761 | 869 | 721 | 2 951 |
| Total debt | 787 | 761 | 869 | 721 | 2 951 |
EBITDA margin
26.2%
This company
15.8%
Market median
+66% vs market
20172021
Equity ratio
65.6%
This company
38.2%
Market median
+72% vs market
20172021
Return on equity
31.5%
This company
18.4%
Market median
+71% vs market
20172021
Net profit margin
21.8%
This company
8.1%
Market median
+169% vs market
20172021
Asset turnover
0.95×
This company
1.12×
Market median
+15% vs market
20172021
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
20172021
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AN Deputy Member | Deputy Member | 2016 |
CN Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2016 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SOS EYE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Adrian Nadau Semb | Deputy Member | 0 companies |
| Claudine Nadau Semb | Chief Executive Officer | 0 companies |
| Svein Ove Semb | Chairman | 0 companies |